Overview
This page compares Arbitrum and Injective with live PEPS metrics. Rankings (#95 vs #99) and liquidity profiles differ, so traders often use them for distinct roles rather than as perfect substitutes.
Quick winners
Full comparison
| Metric | ARB | INJ |
|---|---|---|
| Price | $0.081700 | $5.10 |
| Market Cap | $543.44M | $490.41M |
| FDV | — | — |
| Volume 24h | $4.33M | $2.58M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 95.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.47% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | ARB | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +2.64% | +3.59% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | ARB | INJ |
|---|---|---|
| RSI | 42.16 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.00 | 0.29 |
| ADX | 22.88 | 12.19 |
| Support | 0.08 | 4.91 |
| Resistance | 0.09 | 5.47 |
| Trend | bearish | neutral |
| Momentum | — | — |
| Signal | neutral | neutral |
Automatic technical analysis
Indicator stacks for ARB/INJ currently lean on separate regimes: bearish versus neutral. Treat MACD and RSI as context, not as standalone entry triggers.
Fundamentals
| Metric | ARB | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 4.00 | 0.00 |
| Github activity | 101.00 | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Arbitrum
Injective
Pros and cons
Pros of Arbitrum
- Market-cap scale on Arbitrum may dampen some idiosyncratic shocks versus smaller peers.
- Composite PEPS readings for Arbitrum can surface clearer module agreement during trend phases.
- ARB often anchors narratives that attract sustained media and analyst coverage.
Cons of Arbitrum
- Indicator stacks on Arbitrum may stay stretched longer than expected in strong trends.
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Regulatory or macro headlines can hit Arbitrum harder simply because it is more visible.
- Crowded positioning around ARB sometimes amplifies squeeze or flush risk.
Pros of Injective
- Injective can offer higher relative beta when market attention rotates toward its niche.
- Active volume bursts on INJ sometimes precede sharper tactical moves.
Cons of Injective
- Incomplete fundamental coverage can hide operational or tokenomic risks.
- Trend failures on Injective often travel faster than on more established assets.
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
Which looks stronger right now?
Data currently points to a probabilistic edge for Arbitrum on size and Arbitrum on activity. Neither reading guarantees future returns.
AI summary
In about three hundred words of context: Arbitrum (ARB) trades near $0.081700 with a +2.64% day move, while Injective (INJ) is around $5.10 (+3.59%). Volume leadership currently sits with Arbitrum, and market-cap leadership with Arbitrum. Technical trend labels read bearish vs neutral, with RSI near 42.16/49.29. Bottom line: use this page as a structured checklist, then open each coin page and related PEPS tools before acting. Nothing here is financial advice.
FAQ
Which is better, Arbitrum or Injective?
“Better” depends on horizon and risk. Arbitrum leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, ARB or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Arbitrum and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Arbitrum currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.